144 related articles for article (PubMed ID: 10399796)
1. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures.
Peeters HR; Jongen-Lavrencic M; Bakker CH; Vreugdenhil G; Breedveld FC; Swaak AJ
Rheumatol Int; 1999; 18(5-6):201-6. PubMed ID: 10399796
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.
Peeters HR; Jongen-Lavrencic M; Vreugdenhil G; Swaak AJ
Ann Rheum Dis; 1996 Oct; 55(10):739-44. PubMed ID: 8984939
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin (r-hu-EPO) treatment in patients with rheumatoid arthritis and anaemia of chronic disease (ACD).
Swaak AJ; Nieuwenhuizen C; Vreugdenhil G
Clin Exp Rheumatol; 1994; 12(5):577. PubMed ID: 7842542
[No Abstract] [Full Text] [Related]
4. Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis.
Vreugdenhil G; Manger B; Nieuwenhuizen C; Feelders RA; van Eijk HG; Swaak AJ
Ann Hematol; 1992 Dec; 65(6):265-8. PubMed ID: 1457588
[TBL] [Abstract][Full Text] [Related]
5. Patient utilities in fibromyalgia and the association with other outcome measures.
Bakker C; Rutten M; van Santen-Hoeufft M; Bolwijn P; van Doorslaer E; Bennett K; van der Linden S
J Rheumatol; 1995 Aug; 22(8):1536-43. PubMed ID: 7473480
[TBL] [Abstract][Full Text] [Related]
6. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
7. The relationship of haemoglobin to serum erythropoietin concentrations in the anaemia of rheumatoid arthritis: the effect of oral prednisolone.
Kendall R; Wasti A; Harvey A; Hill J; Chapman C; Norfolk DR; Pullar T
Br J Rheumatol; 1993 Mar; 32(3):204-8. PubMed ID: 8448609
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
Kaltwasser JP; Kessler U; Gottschalk R; Stucki G; Möller B
J Rheumatol; 2001 Nov; 28(11):2430-6. PubMed ID: 11708414
[TBL] [Abstract][Full Text] [Related]
9. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
Takashina N; Kondo H; Kashiwazaki S
J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
[TBL] [Abstract][Full Text] [Related]
10. Applicability of patient utilities as measures of overall quality of life in rheumatoid arthritis clinical trials.
Ward MM; Guthrie LC
Rheumatology (Oxford); 2017 Feb; 56(2):239-246. PubMed ID: 27789761
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin: mechanisms of action and indications for treatment.
Vreugdenhil G; Frenken LA; Koene RA
Neth J Med; 1993 Jun; 42(5-6):187-202. PubMed ID: 8377877
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
[TBL] [Abstract][Full Text] [Related]
13. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.
Strippoli GF; Manno C; Schena FP; Craig JC
Cochrane Database Syst Rev; 2003; (1):CD003967. PubMed ID: 12535495
[TBL] [Abstract][Full Text] [Related]
14. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
15. The role of erythropoietin in the anaemia of chronic disease in rheumatoid arthritis.
Vreugdenhil G; Swaak AJ
Clin Rheumatol; 1990 Mar; 9(1):22-7. PubMed ID: 2185909
[TBL] [Abstract][Full Text] [Related]
16. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin.
Moreno F; Aracil FJ; Pérez R; Valderrábano F
Am J Kidney Dis; 1996 Apr; 27(4):548-56. PubMed ID: 8678066
[TBL] [Abstract][Full Text] [Related]
17. Serum erythropoietin in rheumatoid arthritis and other inflammatory arthritides: relationship to anaemia and the effect of anti-inflammatory treatment.
Birgegård G; Hällgren R; Caro J
Br J Haematol; 1987 Apr; 65(4):479-83. PubMed ID: 3580305
[TBL] [Abstract][Full Text] [Related]
18. The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. The Canadian Erythropoietin Study Group.
Laupacis A; Wong C; Churchill D
Control Clin Trials; 1991 Aug; 12(4 Suppl):168S-179S. PubMed ID: 1663853
[TBL] [Abstract][Full Text] [Related]
19. Patient utilities in ankylosing spondylitis and the association with other outcome measures.
Bakker C; Rutten-van Mölken M; Hidding A; van Doorslaer E; Bennett K; van der Linden S
J Rheumatol; 1994 Jul; 21(7):1298-304. PubMed ID: 7966073
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin β: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients.
Durmaz O; Demirkaya M; Sevinir B
Pediatr Hematol Oncol; 2011 Sep; 28(6):461-8. PubMed ID: 21707225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
